Cabot Global Stocks Explorer 699
Our Emerging Markets Timer as found support in recent weeks, but that hasn’t been enough to produce a new buy signal.
Read More
commodity trading
Read More
commodity trading Archives
Wall Street’s Best Investments 823
Market Views
Still bullish
The broad stock market continues to plow ahead, as $SPX has made new closing or intraday all-time highs on 10 of the last 14 days, including the last two. Thus, momentum is strong and the $SPX chart remains bullish. The $SPX $VIX...
Read More
Cabot Global Stocks Explorer 698
Our Emerging Markets Timer as found support in recent weeks, but that hasn’t been enough to produce a new buy signal.
Read More
Cabot Global Stocks Explorer 697
Our Emerging Markets Timer as found support in recent weeks, but that hasn’t been enough to produce a new buy signal.
Read More
Cabot Global Stocks Explorer 696
Our Emerging Markets Timer as found support in recent weeks, but that hasn’t been enough to produce a new buy signal.
Read More
Wall Street’s Best Investments 822
Market Views
Quiet for Now
Stocks finished a relatively quiet session lower today, after trading on both sides of breakeven amid waning optimism over Friday's partial trade deal between Beijing and Washington. Reports emerged that China wishes to continue trade talks before finalizing the "phase deal,...
Read More
Cabot Global Stocks Explorer test
Our Emerging Markets Timer as found support in recent weeks, but that hasn’t been enough to produce a new buy signal.
Read More
Cabot Global Stocks Explorer 695
Our Emerging Markets Timer as found support in recent weeks, but that hasn’t been enough to produce a new buy signal.
Read More
Cabot Global Stocks Explorer 694
Our Emerging Markets Timer as found support in recent weeks, but that hasn’t been enough to produce a new buy signal.
Read More
Wall Street’s Best Investments 821
Market Views
Shifting to Value
We have a lot of market analysts who are at a loss to understand the rotation(s) that have enabled stocks to work higher (and challenge highs) even at the risk of crying alarms. The hedgers and many technicians do so, the...
Read More
Cabot Global Stocks Explorer 693
Our Emerging Markets Timer as found support in recent weeks, but that hasn’t been enough to produce a new buy signal.
Read More
Cabot Global Stocks Explorer 692
Our Emerging Markets Timer as found support in recent weeks, but that hasn’t been enough to produce a new buy signal.
Read More
Cabot Global Stocks Explorer 691
Emerging markets (EEM) moved more solidly into bullish territory this week moving ahead of both its 20-day and 50-day moving averages.
Read More
Wall Street’s Best Investments 820
Market Views
No Longer Overbought
Technically, the S&P 500 has corrected most of an overbought condition with a 2.73% decline from its July 16 high. News-related volatility will likely continue as the market enters its least favorable season. But, sentiment gauges have begun to improve a..
Read More
Cabot Global Stocks Explorer 690
Emerging markets (EEM) moved more solidly into bullish territory this week moving ahead of both its 20-day and 50-day moving averages.
Read More
Cabot Global Stocks Explorer 689
Emerging markets (EEM) moved more solidly into bullish territory this week moving ahead of both its 20-day and 50-day moving averages.
Read More
Wall Street’s Best Investments 819
Congrats to the Top Picks 2019, Mid-Year
Congratulations to our Top Picks for 2019! For the first half of the year, the Dow Jones Industrial Average was up 11.8%; the S&P 500 gained 14.3%, and the NASDAQ has returned 16.1%. But, as you can from...
Read More
Cabot Emerging Markets Investor 688
Our Emerging Markets Timer is still solidly in the bull camp, with the recent pullback being modest compared to the year-to-date upmove.
Read More
Cabot Dividend Investor Special Bulletin
Early Tuesday morning Biopharmaceutical giant AbbVie (ABBV) announced plans to acquire Ireland-based Allergan plc (AGN) for $63 billion. The market hates the deal and AbbVie stock plummeted over 16% on the day. Let’s take a look at the deal and see what’s going on.
Read More
Cabot Emerging Markets Investor 687
Our Emerging Markets Timer is still solidly in the bull camp, with the recent pullback being modest compared to the year-to-date upmove.
Read More
Enter Your Log In Credentials
- Lost your password? Create New Password
- No account? Sign up